関連する実験動画

Updated: Sep 9, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

薬物遺伝学 (PGx) による抗うつ薬の効果が,不安や感情障害を持つ成人の機能的結果と生活の質に及ぼす影響: 体系的なレビューとメタ解析

Natalia E Fares-Otero¹, Monika Budde², Jonathan Laatsch³

¹Department of Psychiatry and Psychology, Bipolar and Depressive Disorders Unit, Hospital Clínic, Institute of Neurosciences (UBNeuro), Fundació Clínic per a la Recerca Biomèdica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (FCRB-IDIBAPS), Barcelona, Catalonia, Spain; Section for Evidence-Based Medicine in Psychiatry and Psychotherapy, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

|September 1, 2025

まとめ

薬物遺伝学 (PGx) による抗うつ薬の治療は,標準治療と比較して,不安や感情障害を持つ個人の機能を改善する可能性があります. このシステマティック・レビューとメタ分析では,PGxによるアプローチで機能障害の減少が確認されました.

科学分野:

精神科
ファルマゲノミクス
臨床試験

背景:

抗うつ薬の治療効果は個人に大きく異なります.
薬剤遺伝検査 (PGx) は,個別化された抗うつ薬の選択を導くことができます.
機能的アウトカムと生活の質 (QoL) は,治療の成功の重要な指標です.

研究の目的:

通常の治療 (TAU) と対比してPGxによる抗うつ薬治療の有効性を体系的に検討し,メタ分析する.
不安や感情障害の患者における機能的アウトカムとQOLへの影響を評価する.

主な方法:

PRISMAに準拠した7つのデータベースを2025年6月まで体系的に検索する.
2285人の成人を対象とした6件の予期的なランダム化対照試験 (RCT) を含む.
3つの研究におけるバイアスのリスク (RoB2) 評価とランダム効果メタ解析

主要な成果:

PGxによる治療は,TAUと比較して機能障害 (シーハン障害スケール/インベントリー) を有意に減少させた (MD=-2.85,p=.031).
ハルトング・ナップの調整は重要な影響を与えない.
バイアスの全体的なリスクは中等から高かった.

結論:

PGxによる抗うつ剤治療は,不安や感情障害の患者で機能改善の可能性を示しています.
制限には,少数の試験,異質性およびバイアス分析の制限が含まれます.
これらの発見を確認するには,さらに高品質のRCTが必要である.

キーワード:

うつ病障害者機能性について介入精神的健康についてファルマゲノミクス精密精神科ランダム化対照試験

さらに関連する動画

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

関連する概念動画

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Psychosis: Goals of Pharmacotherapy

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.

Factors Affecting Drug Response: Overview

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...